|
| U.S. Brand
Names |
|
| AK-Spore® Ophthalmic Solution;
Neosporin® Ophthalmic
Solution |

|
|
| Generic
Available |
|
|
Yes |

|
|
| Synonyms |
|
|
gramicidin, neomycin, and polymyxin b; polymyxin b, neomycin, and
gramicidin |

|
|
| Pharmacological Index |
|
|
Antibiotic, Ophthalmic |

|
|
| Use |
|
|
Treatment of superficial ocular infection, infection prophylaxis in minor
skin abrasions |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Contraindications |
|
|
Hypersensitivity to neomycin, polymyxin B, gramicidin or any
component |

|
|
| Warnings/Precautions |
|
|
Symptoms of neomycin sensitization include itching, reddening, edema, failure
to heal; prolonged use may result in glaucoma, defects in visual acuity,
posterior subcapsular cataract formation, and secondary ocular
infections |

|
|
| Adverse
Reactions |
|
|
1% to 10%:
Dermatologic: Itching
Local: Reddening, failure to heal
Ocular: Low grade conjunctivitis |

|
|
| Drug
Interactions |
|
|
No data reported |

|
|
| Mechanism of
Action |
|
|
Interferes with bacterial protein synthesis by binding to 30S ribosomal
subunits; binds to phospholipids, alters permeability, and damages the bacterial
cytoplasmic membrane permitting leakage of intracellular
constituents |

|
|
| Usual Dosage |
|
|
Children and Adults: Ophthalmic: Instill 1-2 drops 4-6 times/day or more
frequently as required for severe infections |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
Tilt head back, place medication in conjunctival sac, and close eyes; apply
finger pressure on lacrimal sac for 1 minute following
instillation |

|
|
| Nursing
Implications |
|
|
Tilt head back, place medication in conjunctival sac, and close eyes; apply
finger pressure on lacrimal sac for 1 minute following
instillation |

|
|
| Dosage Forms |
|
|
Solution, ophthalmic: Neomycin sulfate 1.75 mg, polymyxin B sulfate 10,000
units, and gramicidin 0.025 mg per mL (2 mL, 10
mL) |

|
|
Copyright © 2007 Drugs Area
|